Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 7, Issue 10 (2018)

Pulmonary embolism in the therapeutic practice, risk assessment on the example of clinical case

Tetiana Kirieieva, Bogdana Basina and Kseniia Bielosludtseva
Pulmonary embolism (PE) is a “great imitator” and the symptoms of the disease are nonspecific, besides there is a lack of alertness of doctors and patients in terms of the development of this terrible complication. The aim of our work is to assess the risk of PE developing in patients of the therapeutic profile, to identify patients at high risk for determining direct sources of thrombosis and to analyze the most significant factors that can lead to errors in the diagnosis of PE on the example of a clinical case with an unfavorable outcome.
Totally 78 patients were examined. A study of hospitalized patients with a therapeutic profile using the Geneva and Wells scales revealed a high risk of PE in 6,4% of cases. In the high-risk group with the help of additional survey methods, there was a direct threat of PE development and in two cases PE of small branches was confirmed.
Analyzing one clinical case it is worth to remark such reasons for the late diagnosis of PE and an unfavorable outcome as acute leg injury and the presence of DVT, low compliance with the patient, lack of alertness in PE development during hospitalization, unpredictable case anamnesis, reassessment of additional studies (CT) conclusion, late appointment of methods for diagnosing of the localization and massiveness of PE.
Pages: 599-602  |  500 Views  70 Downloads

The Pharma Innovation Journal
How to cite this article:
Tetiana Kirieieva, Bogdana Basina, Kseniia Bielosludtseva. Pulmonary embolism in the therapeutic practice, risk assessment on the example of clinical case. Pharma Innovation 2018;7(10):599-602.

Call for book chapter